Amanda E. Brinker

484 citations

15 papers · 351 indexed · h-index 11

Impact in

Cancer Research
- Cancer, Hypoxia, and Metabolism
Biomaterials
- Nanoparticle-Based Drug Delivery

Papers in ⓘ

Molecular Biology 11
- Mitochondrial Function and Pathology 3
- Polyamine Metabolism and Applications 3
- RNA modifications and cancer 2
Cancer Research 5
- Cancer, Hypoxia, and Metabolism 3

Co-authors: Carolyn J. Vivian (5 shared papers)Danny R. Welch (5 shared papers)Devin C. Koestler (3 shared papers)Evi Lianidou (1 shared paper)Roy A. Jensen (7 shared papers)Wen Liu (1 shared paper)Omar F. Mohammed (1 shared paper)Snigdha Banerjee (1 shared paper)
Journals: Cancer Research (4 papers)Journal of Clinical Oncology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Cell Cycle (1 paper)Cell Death and Disease (1 paper)
Partner nations: United States United Kingdom Türkiye

In The Last Decade

Amanda E. Brinker

15 papers receiving 347 citations

Peers

Countries citing papers authored by Amanda E. Brinker

Since Specialization

Citations

This map shows the geographic impact of Amanda E. Brinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda E. Brinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda E. Brinker more than expected).

Fields of papers citing papers by Amanda E. Brinker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda E. Brinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda E. Brinker. The network helps show where Amanda E. Brinker may publish in the future.

Co-authors

The 25 scholars most cited alongside Amanda E. Brinker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amanda E. Brinker Line = papers co-authored together Amanda E. Brinker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	The Impact of Nanoparticles on the Immune System: A Gray Zone of Nanomedicine Priyanka Ray, Noor Haideri, Inamul Haque, Omar F. Mohammed, Saborni Chakraborty, Snigdha Banerjee, Mohiuddin Quadir, Amanda E. Brinker, Sushanta K. Banerjee	2021	76
2	Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell’s Journey Cancer Microenvironment ·Wen Liu, Carolyn J. Vivian, Amanda E. Brinker, Kelsey R. Hampton, Evi Lianidou, Danny R. Welch	2014	51
3	Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression Cancer Research ·Carolyn J. Vivian, Amanda E. Brinker, Stefan Graw, Devin C. Koestler, Christophe Legendre, Gerald Gooden, Bodour Salhia, Danny R. Welch	2017	48
4	Mitochondrial Haplotype Alters Mammary Cancer Tumorigenicity and Metastasis in an Oncogenic Driver–Dependent Manner Cancer Research ·Amanda E. Brinker, Carolyn J. Vivian, Devin C. Koestler, Trevor Tsue, Roy A. Jensen, Danny R. Welch	2017	30
5	Zinc Finger Nuclease–Mediated Gene Knockout Results in Loss of Transport Activity for P-Glycoprotein, BCRP, and MRP2 in Caco-2 Cells Drug Metabolism and Disposition ·Kathleen E. Sampson, Amanda E. Brinker, Jennifer R. Pratt, Neetu Venkatraman, Yongling Xiao, Jim Blasberg, Toni Steiner, Maureen Bourner, David C. Thompson	2014	28
6	Reduced O-GlcNAcase expression promotes mitotic errors and spindle defects Cell Cycle ·Chris Lanza, Ee Phie Tan, Zhen Zhang, Miranda Machacek, Amanda E. Brinker, Mizuki Azuma, Chad Slawson	2016	25
7	Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs Journal of Pharmacology and Experimental Therapeutics ·Scott J. Weir, Robyn Wood, K.S. Schorno, Amanda E. Brinker, Prabhu Ramamoorthy, Kathy Heppert, Lian Rajewski, Mehmet Tanol, Tammy Ham, Michael J. McKenna, William McCulloch, Michael Dalton, Gregory A. Reed, Roy A. Jensen, Michael Baltezor, Shrikant Anant, John A. Taylor	2019	17
8	Mitochondrial Haplotype of the Host Stromal Microenvironment Alters Metastasis in a Non-cell Autonomous Manner Cancer Research ·Amanda E. Brinker, Carolyn J. Vivian, Thomas C. Beadnell, Devin C. Koestler, Shao Thing Teoh, Sophia Y. Lunt, Danny R. Welch	2019	17
9	New insights into the clinical pharmacokinetics of trofosfamide International Journal of Clinical Pharmacology and Therapeutics ·Amanda E. Brinker, Jens Kisro, C Letsch, S K Brüggemann, Thomas Wagner	2002	14
10	Use of Zinc Finger Nuclease Technology to Knock Out Efflux Transporters in C2BBe1 Cells Current Protocols in Toxicology ·Jennifer R. Pratt, Neetu Venkatraman, Amanda E. Brinker, Yongling Xiao, Jim Blasberg, David C. Thompson, Maureen Bourner	2012	13
11	Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex Cell Death and Disease ·Scott J. Weir, Prasad Dandawate, David Standing, Sangita Bhattacharyya, Prabhu Ramamoorthy, Parthasarathy Rangarajan, Robyn Wood, Amanda E. Brinker, Benjamin L. Woolbright, Mehmet Tanol, Tammy Ham, William McCulloch, Michael Dalton, Gregory A. Reed, Michael Baltezor, Roy A. Jensen, John A. Taylor, Shrikant Anant	2021	11
12	Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models Cancer and Metastasis Reviews ·Carolyn J. Vivian, Travis M. Hagedorn, Roy A. Jensen, Amanda E. Brinker, Danny R. Welch	2018	9
13	Pharmacokinetics of ciclopirox prodrug, a novel agent for the treatment of bladder cancer, in animals and humans. Journal of Clinical Oncology ·Scott J. Weir, Robyn Wood, Michael Baltezor, Greg Reed, Amanda E. Brinker, Tammy Ham, K.S. Schorno, Paul Toren, Prabhu Ramamoorthy, Valentina Zhukova-Harrill, Michael Dalton, William McCulloch, Manish R. Patel, Susanna V. Ulahannan, Howard A. Burris, Gerald S. Falchook, Roy A. Jensen, Shrikant Anant, John A. Taylor	2019	6
14	Preclinical development of ciclopirox prodrug for the treatment of non-muscle invasive and muscle invasive bladder cancer. Journal of Clinical Oncology ·Scott J. Weir, Robyn Wood, Tammy Ham, Parthasarathy Ranjarajan, Prabhu Ramamoorthy, Lian Rajewski, Kathy Heppert, John L. Haslam, K.S. Schorno, Michael Dalton, Michael J. McKenna, Greg Reed, Amanda E. Brinker, William McCulloch, Michael Baltezor, Roy A. Jensen, John A. Taylor, Shrikant Anant	2018	4
15	Abstract 5882: Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer Cancer Research ·Scott J. Weir, Partha Ranjarajan, Robyn Wood, K.S. Schorno, Prabhu Ramamoorthy, Lian Rajweski, Kathy Heppert, Michael J. McKenna, William McCulloch, Greg Reed, Amanda E. Brinker, Michael Baltezor, Roy A. Jensen, John A. Taylor, Shrikant Anant	2018	2

About Amanda E. Brinker

Amanda E. Brinker is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Surgery and Pathology and Forensic Medicine, having authored 15 papers that have together received 351 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Mitochondrial Function and Pathology (3 papers), Polyamine Metabolism and Applications (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), RNA modifications and cancer (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Metabolism and Genetic Disorders (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Cancer Research (76 citations), Biomaterials (43 citations), Molecular Biology (207 citations), Oncology (77 citations) and Clinical Biochemistry (19 citations). Amanda E. Brinker has collaborated with scholars based in United States, United Kingdom and Türkiye. Frequent co-authors include Carolyn J. Vivian, Danny R. Welch, Devin C. Koestler, Evi Lianidou, Roy A. Jensen, Wen Liu, Omar F. Mohammed, Snigdha Banerjee, Saborni Chakraborty and Mohiuddin Quadir. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics, Cell Cycle and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact